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Abstract
Laminitis is an often fatal condition in horses with few available and only moderately effective
treatment options.

Separation of laminar dermis and epidermis lead to rotation or ventral

deviation of the third phalanx inside the hoof capsule. Despite being a modified skin, equine
laminar tissue does not completely return to normal after laminitis. The hypothesis tested was
that adult progenitor cells in the equine laminar tissue are irreversibly damaged by laminitis. A
method to harvest and culture cells in vitro from the equine lamina was established; and
progenitor cells from unaffected and laminitic hooves were characterized and compared.
Laminar tissue was harvested from horses with and without evidence of laminitis. Cells were
isolated from each tissue type, unaffected (UC) and laminitic (LC). Cell doublings (CD) and
doubling times (DT) were quantified for passage (P) 0-5 cells. For P0, 2, and 5, fibroblastic
colony forming units (CFU-F), progenitor (OCT4, SOX-2, CD29, CD44, and CD105) and
keratin (K14, K15, and K19) target gene mRNA levels (qRT-PCR) and protein expression (flow
cytometry) as well as multipotentiality were assessed.

Keratins were localized with

immunohistochemistry.
Overall LC CD was significantly higher than UC.

Progenitor gene mRNA levels were

significantly higher in P0 LC versus UC. K14 and K15 mRNA levels in P0 were lower in LC
when compared to UC. Keratins were localized to secondary epidermal lamina. Osteogenic,
adipogenic and chondrogenic differentiation was confirmed in both cell types
Increases in progenitor mRNA in UC over passages is consistent with selection of progenitor
cells by plastic affinity and confirms maintenance of progenitor cell characteristics through
multiple passages. Results of this study highlight specific progenitor cell changes in laminitic
hooves that result in a constant state of hyperproliferation without cell maturation.

ix

These

changes may explain the abnormal tissue organization and function that result from laminitic
episodes. The procedures developed in this study provide a unique and consistent model to study
the intricacies of equine laminitis in the horse. Future studies using the model designed here will
be used for in vitro investigations aimed at identifying specific mechanisms to reverse or prevent
the cellular changes from laminitis.

x

1. Introduction
Laminitis occurs in approximately 15% of horses in the United States yearly, and, 75% of those
affected, more than 8,000, are euthanatized. The cost of laminitis diagnosis and treatment is over
$10 million per year in the US. Laminitis was originally described by Aristotle in 30BC. In the
16th century, it was called founder, and in the 18th century given the modern title of laminitis [1].
Despite decades of research focused on this devastating disorder there has been relatively little
progress to prevent or treat it.
Multiple conditions and factors result in laminitis including, but not limited to, intestinal
obstruction, retained fetal membranes, pleura-pneumonia, supporting limb (from orthopedic
injuries), and endocrine/metabolic diseases [2]. Dietary insults, such as grain engorgement
(overload) or overfeeding grain and grass, and obesity, can lead to laminitis. Equine metabolic
syndrome is characterized by insulin resistance, regional or generalized adiposity, and current or
a history laminitis.[3]
Supporting limb laminitis is a common complication of severe orthopedic injuries, and the
incidence increases with duration of lameness [4].

Based on a retrospective study, horses

requiring full limb or transfixation pin casts following surgery have a 10% higher incidence of
supporting limb laminitis than horses with half limb casts [5].
Conditions requiring laparotomies such as colic or hernia predispose to laminitis, which occurs
in 3.4% of the 45.8% of horses that have post-surgery complications, highest during the summer
months [6]. Regardless of the inciting cause, laminar tissue within a hoof affected by laminitis
does not return to normal growth and morphology, and must be permanently managed to
maintain comfort and function [7].
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Adult multipotent stromal cells (MSCs) found in most mammalian tissues including bone
marrow, adipose tissue, muscle, brain, liver, synovium and periosteum, among others may offer
a potential new therapy for laminitis [8-13]. Stromal cells have promise for tissue regeneration
because of their ability to differentiate into diverse cell lineages and their characteristics of selfrenewal and immune privilege [14-17]. The majority of work on adult equine MSCs has focused
on isolation and characterization of mesenchymal cells from bone marrow and fat and
therapeutic application in tendon and/or cartilage [4, 18-20]. Equine lamina is a specialized
epithelial structure similar to human skin, which contains epidermal progenitor cells [21].
Laminar progenitor cells, however, are largely unexplored [22, 23]. Scientific evidence shows
that laminar tissue formed after severe laminitis contains dyskeratinized (abnormal and
premature keratinization) epidermal cells, suggesting abnormal formation and/or maturation of
native progenitor cells [24].
The majority of research to elucidate events occurring within the laminitic hoof capsule relies on
induction of laminitis in otherwise normal horses by administration of toxins or an overdose of
carbohydrate which leads to and requires humane euthanasia [25-28]. Other models are limited
by mechanical injury of otherwise hoof to evaluate healing potential within a relatively small
region of the hoof. It is possible that currently available models do not recreate the complex
systemic and cellular physiology of laminitis. Understanding of progenitor cells within the
laminae may contribute vital information for prevention and treatment of laminitis. Increased
awareness of and application of novel approaches to prevent and treat laminitis will significantly
augment the current armamentarium against this devastating condition.
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2. Literature Review
2.1. Structure of the Equine Hoof Capsule
The equine hoof capsule is a cornified modified epidermis that covers the tip of the digit. It is
composed of five regions: the periople, the wall, the white line, sole, and the frog. The wall
itself is composed of three strata.

From outside to inside they include the stratum

externum/tectorium, medium and internum/lamellatum. The stratum externum consists of a few
millimeters of cornified tissue, and it is formed by multiplication of germinal cells at the
perioplic corium, it is proximally covered by the periople and lays on the coronary corium,
which produces the stratum medium [29]. The stratum medium, the thickest layer of the hoof, is
composed of pigmented tubular and intertubular horn, crucial for hoof mechanical stability and
protects the sensitive hoof layers against harmful substances and microorganisms. The tubular
and intertubular horns are formed by proliferation of basal epidermal cells on the papillae of the
coronary corium. As new cells are formed, older cells advance distally for hoof wall growth. As
the cells move distally, they keratinize and eventually become cornified. The focus of this
research is on the innermost layer, the stratum internum (lamellatum).
The nonpigmented stratum internum has two main, interdigitated components, the epidermal and
dermal laminae, which are continuous with the tubular horns of the stratum medium and the
periosteum of the distal phalanx, respectively. The epidermis is non-sensitive and avascular
while the dermis is sensitive and vascular [30]. It is composed of arteries, veins, capillaries and
sensory and vasomotor nerves within a dense matrix of tough connective tissue. The inner
surface of the epidermal layer and the outer surface of the dermal layer have frond-like shapes,
primary laminae, which are interdigitated with each other. Upon each primary lamina are
smaller secondary lamina, which have frond like structures. Each primary laminar frond has
3

approximately 200 secondary laminar fronds. Between the secondary fronds is the basement
membrane which contains hemidesmosomes and collagenous fibril anchors that connects basal
cells of the secondary epidermal lamina (SEL) to the secondary dermal lamina (SDL). The
basement membrane facilitates nutrient and growth factor exchange between the two structures
and forms the natural scaffold that stabilizes the hoof and orientates the proper development,
maturation and maintenance of the hoof epidermis [30].
The avascular and non-sensitive laminar epidermis is intimately attached to the vascular and
sensitive dermis [30]. The dermis is a dense matrix of tough connective tissue with arteries,
veins and capillaries and sensory and vasomotor nerves, plays a suspensory role within the hoof.
The epidermis basal cells are intimately connected the dermis by the basement membrane. The
basement membrane between dermis and epidermis is composed of ultramicroscopic
hemidesmosomes and anchoring collagenous fibril structures, and it facilitates nutrient and
growth factor exchange between the two structures [30]. The laminae themselves consist of
primary (PDL) and secondary (SDL) dermal and primary (PEL) and secondary (SEL) epidermal
laminae. To increase the surface area and resistance of weight bearing there are 555-600 PELs
and 200 SEL of off each PEL. SDL branches from PDL which connects with SEL branching
from PEL. The integrity of the basement membrane, PEL, SEL, PDL, SDL is important since it
forms the natural scaffold that stabilizes the hoof and orientates the proper development,
maturation and maintenance of the hoof epidermis.
To date the stratum internum cell renewal is largely unexplored. The tubular horns, while
growing, tension the epidermal and dermal structures, which keep the orientation of the hoof
growth. The length and thickness of the PEL slight increase from the proximal to the distal parts
of the hoof. Also the number of cornified cells is higher towards the toe region. It is unknown
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whether the laminar epidermal cells proliferate from progenitor cells in the coronary band region
and grow continuously with the tubular horns, or whether the renewal occurs from progenitor
cells present in the axial epidermal laminar cells.
Structures within the hoof capsule change throughout the horse’s life, with major transformation
occurring during the first year. The epidermal laminae within the stratum internum start to
change after birth to become more dense and elongated by one year of age [31, 32]. Studies of
the microstructure of the laminae have evaluated and classified patterns in the laminar tissue,
besides the ones observed during development from newborn to adult. Morphology of the PEL,
SEL and PEL tip has been described and classified into several patterns or types considering
length, width, branching, symmetry, and tip morphology of PEL [33]. Age and mechanical
stimulation can lead to alterations that may or may not result in clinical and subclinical laminitis.
The laminar morphology diversity explains how challenging is to determine what is normal and
what is abnormal in the laminar tissue.
2.2. Keratins and the Hoof Capsule
Keratins are non-soluble proteins specific of epithelial tissues that are crucial to the structure and
development of healthy hoof and are a major component of epidermal tissues [34]. Disulfide
bonds, within the keratin molecules convey strength and hardness. The more disulfide bones, the
harder the tissue. Hard keratins are present in tissues such as hair, feathers, nails and hoof walls
[35]. Soft keratins are found in tissues such as skin, cuticle and periople. Recently, 30 keratins
along with vemetin, desmin, peripherin, internexin, 2 laminin filament proteins and 6
microtubule proteins were identify in the laminar tissue. [36]. These findings are important as
keratin protein profiles may change in disease and affects the hoof wall and correlates with loss
of laminar tissue function as with laminitis.
5

Keratins are produced by keratohyaline granules in the specialized basal cells of the epidermal
layers called keratinocytes [35]. Keratinocytes are one of the specialized cell lineage derived
from the epidermal progenitor cells. Progenitor cells from the epidermis differentiate into stem
cells, transient amplifying cells and keratinocytes. Stem cells keep continuously dividing into
stem cells, transient amplifying cells and keratinocytes.

Transient amplifying cells and

keratinocytes migrate and undergo final differentiation and keratinization depending on the
tissue they are localized, hair follicle, sebaceous glands, basal epidermal cells [37, 38].
Keratinocytes are crucial to epidermal tissue growth and regrowth after injuries and either
establish or reestablish structure for proper tissue function [21, 39]. Keratinocytes are important
to normal epidermal tissue health, such as the hoof capsule and epidermal growth factor and
fibroblast growth factor stimulate the modification and differentiation of epidermal tissues [39,
40]. They are the earliest stage of differentiation of basal epidermal laminar cells. Failure of the
cells to differentiate into mature keratinocytes or keratinocytes that do not produce specific
keratins for their specific tissue may cause laminitis. Studies have reported that specific keratins,
K6, K16, and K17 are expressed locally in the wound center, while K10 expressed on suprabasal
cells on wound edge.

This cellular keratin expression defines cell function in the tissue

according to the required repair, e.g. proliferation, differentiation or maturation [41].
Keratinocytes from human skin can be induced to epidermal tissue with similar morphology to
the human skin [40]. Epidermal morphogenesis in vitro depends on various growth factors, such
as keratinocyte growth factor, epidermal growth factor and insulin-like growth factor, especially
when a non-cellular substrate is used to cultivate the progenitor cells. This suggests that in the
right environment epithelial cells, such as laminae, can be successfully regenerated in vitro.
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The equine hoof lamina is a dynamic tissue that is in constant transition and formation from birth
throughout the life of the horse. Some transitions and modifications of hoof lamina are normal
and occur with aging and/or the result of weight bearing while others occur in response to local
or systemic pathological conditions. However, tissue damage is characterized by inflammation
and edema of the lamina (laminitis) and ventral deviation or sinking of the third phalanx in the
hoof capsule.
2.3. Experimental Laminitis Models
Laminitis can be divided into phases based on its progression: developmental, acute, subacute
and chronic. The developmental phase occurs between the first insult and the appearance of
initial clinical signs, and its duration depends on the initiating factor. The acute phase is defined
as the time when first clinical signs occur until mechanical movement of the third phalanx occurs
which is usually within 72 hours. If sinking or ventral deviation of the third phalanx, does not
occur within 72 hours laminitis is classified as the subacute stage and if failure of the third
phalanx occurs after the subacute stage then it is considered the chronic phase [42].
Over the past 40 years experimental models, such as endotoxemia, CHO and BWE, have been
used to study laminitis [25-28]. In these laboratory models, horses develop similar clinical signs
as in naturally acquired laminitis, such as increased heart rate, hypotension, increased rectal
temperature, leukocytosis or leukopenia, hyperproteinemia.

Increased packed cell volume,

decrease laminar perfusion and capillary collapse within the hoof lead to increased vascular
resistance and increased capillary pressure, resulting in laminar ischemia and edema [43, 44].
Models to induce laminitis are based on known causes of laminitis; however pathologic changes
in the hoof and clinical signs vary among horses given the same dose of toxicant.
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Since endotoxemia is one of the causes of laminitis, the endotoxemia model was based on
intravenous administration of exogenous endotoxin to horses which resulted in systemic
hypotension, release of cellular cytokine and a direct effect on capillary endothelial function and
palmar digital artery constriction [45]. This method is based in natural occurring endotoxemia
secondary to enteritis, pneumonia, retained fetal membranes and peritonitis which are associated
with a risk of laminitis [46]. Endotoxin administration results in release and activation of
inflammatory mediators, alteration in endothelial permeability and activation of the coagulation
cascade. Typically, clinical signs seen after endotoxin administration include fever, increased
heart rate and respiratory rate [47, 48]. Despite naturally occurring endotoxemia being a risk
factor of developing laminitis, the administration of pure endotoxin intravenously did not cause
laminitis in horses. For instance administration of E. coli (0.03g/kg, IV) endotoxin resulted in
vascular changes, including arterial vasoconstriction and digital hypoperfusion; however horses
did not develop clinical laminitis [25]. Therefore other models were developed to induce
naturally occurring laminitis.
The carbohydrate overload laminitis model (CHO) was first described in 1975 by Garner et al
(1975) and is based on administration of corn starch and wood cellulose flour via nasal-gastric
tube [26]. The CHO administration results in alteration in the cecal microflora, production of
lactic acidosis and endotoxemia [26].

Histopathological sections of hooves from affected

horses, following the onset of the lameness show swelling of endothelial cells and mild laminar
edema [49]. Also, there is erythrocytes and leukocytes accumulation in laminar capillaries and
leukocytes infiltration in epidermal layers [50]. Furthermore, in one study 8 to 12 hours after
CHO administration, arteriolar endothelial cells were deformed [51]. Hoof laminar tissue is thin
and lengthened from its original structures and epithelial cells are reduced in number. After 24
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hours, there was disintegration (necrosis) of the basement membrane; which is the structure that
keeps epidermis-dermis interdigitated [30].
The Black Walnut extract (BWE) model was first described by Minnick et al in 1987 [27].
Shavings of the Black Walnut tree heartwood are soaked in water and the straining resulted in a
dark tea which is administrated to the horses via nasogastric tube. Depression, coronary band
edema, leucopenia, and foot pain, all signs of laminitis, are detected 12 hours after
administration. However, diarrhea or endotoxemia do not occur as with the CHO model. In this
model histological section of laminae showed vacuolization of the SEL and PEL tips loss of
cellular definition and necrosis. Blood flow within the hoof, as measured by Doppler flow,
decreased within the hoof capsule during the two hours after BWE administration, leading to a
decrease in hoof wall temperature [44].
The oligofructose model was developed to induce laminitis and causes less morbidity when
compared to CHO model [52]. Fructan is short chain sugar containing fructose molecules. It is
derived from chicory root and when administrated to horses via nasogastric tube results in
reproducible clinical signs of laminitis. The dose of oligofructose can be tittered to produce
consistent signs of laminitis than the methods described above [28]. Horses consistently develop
pyrexia, increased heart rate, hematological alteration and diarrhea. French and Pollit (2004)
also showed that hemidesmosomes are lost in the SEL after oligofructose administration. The
number of SEL lost correlates with the dose of oligofructose administrated [53].
2.4. Circulatory, Endocrine and Inflammatory Contributors to Laminitis
All alterations that occur in the laminar tissue during laminitis have been related ultimately to
decrease of blood flow once an inflammatory response takes place, independently of the primary
insult. There is a vasoconstriction of the laminar capillaries, resulting in hypoxia, at the onset of
9

laminitis, however this event by itself it is not sufficient to explain all the mechanisms that result
results in laminar changes and clinical laminitis.
The blood vessels in the equine hoof are very sensitive to vasoactive substances such as
norepinephrine and endothelin, and blood flow changes are seen in normal horse during weight
shifts or normal activity [54, 55]. There remains a finally regulated balance of blood flow to and
within the laminae of the hoof which is susceptible to alterations during disease states.
Furthermore the lamina is located between the distal phalanx (bony tissue) and the hoof wall, and
does not provide an opportunity to swell during conditions that increase peripheral venous
pressure in the hoof. This predisposes the lamina to edema and compression injury, oxygenation
deficit and that may eventually result in detachment of dermis from the epidermis. Without
dermis and epidermis attachment, the tension of the deep digital flexor tendon (which is attached
to the extensor process (ventral) of the third phalanx) functions to pull the third phalanx ventral
resulting in the characteristic “coffin” rotation seen in laminitis [56].
Endocrine related laminitis has been investigated, and can also be related to inflammatory
response. It is characterized by laminitis occurring in horses due equine metabolic syndrome
(obesity, insulin resistance), pituitary pars intermedia dysfunction (equine Cushing’s syndrome),
and excess endogenous glucocorticoid release (endogenous) or administration (exogenous) [3,
57].

Although in humans all those factors are related to metabolic syndrome, the same

relationships in horses are not well understood [58]. Obesity’s relationship with laminitis can be
explained by the fact that adipose tissue secretes TNF-α, IL-1β IL-6, which are an inflammatory
cytokine that inhibits insulin receptor signaling, decreasing insulin sensitivity [59, 60]. It has
been already shown that ponies with laminitis have a higher concentration of TNF-α than healthy
ponies [60]. Omental obesity is associated with overexpression of 11β-hydroxysteroid

10

dehydrogenase-1 (11β-HSD1) which converts cortisone in active cortisol.

Cortisol is a

secretagogue of leptin, which is produced by adipocytes and is elevated in obese patients with
insulin resistance, type 2 diabetes, and hyperlipidemia [57]. Increased inflammatory cytokines
and endocrine changes due to obesity have been related to disturbed homeostasis within the hoof
[59].
Systemic inflammation may be present in horses with laminitis, and may be the trigger that
initiates the development of clinical signs. Studies have shown that mRNA expression of
cytokines (e.g. interleukin [IL]-1β, cyclooxygenase [COX] 2) increases in the early stages of the
disease [61]. In laminitis induced by BWE, increased interleukin [IL]-8 expression is probably
associated with the neutrophil infiltration into laminar tissue and occurs within the first 3 hours
after administration, which then is followed by an increased expression of IL-1β and IL-6 and a
decreased expression of IL-10, an anti-inflammatory cytokine [61].

On the other hand

oligofructose administration showed innate and helper T cell 1 adaptive immune response,
cytokine such as

IL-2, IL-6, IL-8 and interferon, which also is observed when systemic

inflammation is induced by Escherichia coli [61]. These observations confirm that inflammatory
response plays an important role in laminitis pathogenesis.
Naturally or experimentally the precise equilibrium controlling laminar hoof growth and
regeneration is disrupted during laminitis. This equilibrium is maintained by synthesis and
degradation of the extracellular matrix (ECM) in endothelial cells as normal process. This
process is regulated and controlled by tissue inhibitors of metalloproteinases (TIMPs), slightest
alteration in the balance may result in irreversible tissue loss due to degradation of ECM by
metalloproteinases (MMPs) [62]. Pro-inflammatory cytokines (IL-1β and IL-8) also are related
to up-regulation of MMPs in some tissues [63]. MMPs are also released by neutrophils, which
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are attracted by IL-8 during laminitis [64]. Proteins are the substrate for enzymes, such as
MMPs, in the laminar tissue laminin is a protein that functions to anchor the epidermis to the
dermis within the hoof, and is a MMPs substrate easily metabolized [65]. It has been shown that
laminitic tissue contains higher levels of specific MMPs (MMP-2 and -9), which explains
degradation of ECM and epidermis-dermis separation during laminitis [66].
Laminitis is a severe manifestation resulting in several clinical local and systemic conditions.
The final outcome is a failure of dermis-epidermis cement and detachment followed by ventral
deviation or rotation of the third phalanx. In order to understand and relate all the factors and the
respective effects inside the hoof capsule, further research is needed to determine what are
normal and abnormal structure and function, and the cell signaling pathways that ultimately are
irreversibly compromised.
2.5. Multipotent Stem/Stromal Cells Characteristics
Multipotent cells are capable of becoming different cells of distinct tissues, they are also known
for their self-renewing and immune privilege capacity, making them interesting tools in
regenerative medicine therapies [14, 15]. These cells are found in embryonic and adult tissue.
Adult mesenchymal stromal cells are found in most of the tissues in the body and have been
isolated from bone marrow, adipose tissue, muscles, brain, liver, synovium and periosteum in
different species [8-13, 17, 67].
Stem cells are present among the stromal mesenchymal cells and can divide many times without
differentiating. Stem cells can be totipotent, pluripotent, multipotent or unipotent depending on
the tissues they differentiate into. Totipotent cells are able to differentiate into any cells found in
the organism, such as a fertilized egg. Pluripotent stem cells are able to differentiate into several
cell types within the same embryonic layer, endoderm (e.g. lung cells); mesoderm (e.g. muscle
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and bone); or ectoderm, (e.g. skin and neurons). Multipotent cells (e.g. mesenchymal stromal
cells) can differentiate in different tissues within the same germ layer. Finally, unipotent stem
cells can only become one cell type. [68]
In order to unify the characteristics that define multipotent mesenchymal stem cells derived from
adult human tissues, the International Society of Cellular Therapy (ISCT) stated that stem cells
must be plastic-adherent, express specific cell surface markers, such as CD73, CD90 and CD105
and lack the expression of CD14 or CD11b, CD34, CD45, CD79α or CD19 and MHC-II [69].
Also it has been reported that stem cells express CD29, CD44, CD106 and CD166 [70]. In
addition to immunophenotype, these cells must be capable of differentiating into osteocytes,
adipocytes and chondrocytes under specific culture conditions. The ISTC recommends the term
stem cells to be reserved just for the cells that show all the characteristics specified above and
also cells with long-term life in vivo with self-renewal capabilities [71].
The ability to isolate multipotent cells, as well as expand and differentiate them in vitro gives a
new clinical perspective in medical research and raises new therapeutic possibilities. In equine
veterinary practice, since fractures and laminitis have poor recovery rate, stem cells provide a
new approach towards regenerative therapies. Equine stem cells have been isolated from adult
tissue such as bone-marrow and adipose, and embryonic tissue such as umbilical cord blood.
Plastic adherence, immunophenotype, and successfully differentiation into different cell lineages
were studied and confirmed by several investigators, which verifies their stem cell profile is
similar to the human established patterns [16, 19, 72].
Stromal cell therapy is promising for injuries and diseases, such as tendinitis, arthritis and
laminitis, however little work has been done in this area. Recently it was reported that an
injection of autologous stem cells into a laminitic hoof proved successful for tissue recover [73].
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Furthermore in horses, bone marrow derived mesenchymal cells have been injected into tendons
to repair tendon injuries, but the efficacy of the therapy is difficult to determine since control
groups are rarely reported and frequently therapy is mixed with other cells and biological factors
(e.g. serum and/or platelet) [15, 74]. New studies are still needed to determine how stromal cells
can be efficiently used in regenerative therapies.
2.6. Epidermal Stem/Stromal Cells
A distinct stem cell population is found in the epidermis.
maintaining and renewing the skin integrity.

These cells are important in

Depending on the stimuli, stem cells in the

epidermis will differentiate into sebaceous gland, hair follicle, keratinocytes, transit-amplifying
cells and stromal cells [75-77]. In the epidermis, cells from the basal layer are responsible for
the normal cyclic tissue renewal. These basal cells are progenitor cells and divide into new
progenitor cells, also known as kerationocytes, or terminate into differentiated epidermal cells
[78]. During epidermal tissue repair the epidermis recruits a pool of progenitor cells, in order to
repair the wound [79]. In this process keratinocytes are important for inter- and intracellular
interactions within the skin. They coordinate the signals from various growth factors, cytokines,
ions and adhesion molecules, and direct the epidermis renewal.
Keratinocytes and keratinoblasts are the progenitor cells in the epidermis basal layer of the
stratified epithelia, and produce all cell types. The expression of keratins 5, 14, 15 and 19 by
these cells indicate they are non-differentiated [80]. As they differentiate the keratin expression
changes, which characterize each cell lineage. For example, stem cells initially express keratins
7, 8, 17, 18 and 20; transient amplifying cells express keratin 6 and 16, and primordial
keratinocytes, that terminate in cornified epithelium express keratin 1 and 10 initially, then later
keratins 2 and 9 [21, 81, 82]. Keratins 15 (K15) and 19 (K19) expression on basal keratinocytes
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decrease with age. A combined expression of those two keratins indicates cells capable of selfrenewing and lateral expansion of growing skin [70, 83, 84]. Keratinocytes isolated from canine
hair-follicle showed a high cell proliferation rate, as stem cells, and were also positive for K15
and CD34 [85].

Therefore, the expression of specific keratin markers by epidermal cells

indicates a specific level of cell differentiation.
Being able to characterize the heterogeneous cell population within the epidermis and distinguish
each type of cell is also very important for understanding this dynamic tissue [86]. Using specific
markers, these cells can be sorted and studied.
Epidermal stem cells, which express integrin β-1 (CD29) and Keratin 19 have been isolated from
human, mice and porcine skin and differentiated into different cell lines of the epidermis [37, 38,
87, 88].

Stem cells from the porcine skin can give rise in vitro to neuro-muscular cells,

fibroblast-like stem cells derived from human fore-skin (FDSCs) express CD90, CD105, CD166,
CD73, SH3 and SH4 which are similar markers as bone marrow derived stromal cells. The skin
stem cells have been also proven to be multipotent by induction to different lineages and
successfully differentiation into osteocytes, adipocytes, neural cells, smooth muscles, Schwannlike cells and hepatocyte-like cells [89, 90]. Cells harvested from epidermal tissues have a
stromal cell population capable of differentiating into diverse cell lineages from ectodermal,
endodermic and mesodermic tissues.
2.7. Stem/Stromal Cells Therapy
Using stem cells as a therapeutic alternative has been the objective of regenerative medicine
research. Prior to medical and veterinary clinical application, animal models are used to study
cell effect and fate once in vivo. Several rat and mouse models have been used to investigate
human diseases. One successful application of stem cells was achieved to treat a fatal
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neurodegenerative disease mice model, which cause neural dysfunction leading to paralysis
(Amyotrophic Lateral Sclerosis [ALS]), where intra-muscular transplantation of human
mesenchymal stem cells proved to ameliorate damaged site with cellular regeneration in treated
animals confirming their potential to regenerate tissue and improve patient condition [91].
A pilot study conducted with patients that had suffered and survived from myocardial infarction,
and presented irreversible tissue damage showed the therapy potential of MSCs. Cells were
isolated from all 10 patients that participated in the study and infused with a cardiac
catheterization suite to the proximal part of the coronary vessel. After 8 weeks all patients had
infarcted size decreased by 5.84% with left ventricle geometry and function preserved [92].
Assisting regeneration of epithelial cells after diseases and injuries is also another goal of stem
cell therapies. The body faces a challenge when regenerating a loss of large tissue volume, such
as skin loss in burnt patients; or in lung diseases, as cancer, when pulmonary tissue is replaced
by fibrosis. In both cases the original tissue is replaced with a scar tissue that is not functioning,
in the lungs for example the fibrosis are breathless. Studies have been done to verify the stem
cell potential to regenerate epithelial cells. Mesenchymal stem cells were used as a therapeutic
option in a murine model of bleomycin lung injury and an emphysema model with the
improvement of the condition suggesting stem cells potential to regenerate epithelial injured
tissue [93, 94].
Recessive dystrophic epidermolysis bullosa a is an inherited skin disorder in humans that disturb
the homeostasis of the epidermis and dermis resulting in blistering and depleting of stem cell
pool in the skin [95]. The pathology of the disease evolves lack of anchoring fibrin and collage
VII at the dermal-epidermal junction [96]. Both fibroblast and keratinocytes secrete collagen VII
and can be used as an alternative to restore the basement membrane [97]. Conget et al (2010)
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reported the intradermal injection of allogeneic BMSCs in two patients, which resulted in an
increase in collagen VII in the dermal-epidermal junction in chronic ulcerated skin [98]. Also
intradermic injection of fibroblasts from the patient's skin was proven to restore the basement
membrane structure [99].
In equine veterinary medicine the regenerative capacity of stem cells was also studied. Most
applications of stem cell involve injection into tendons for tendonitis and into ligament for
desmitis [100-102]. In a collagenase tissue induced tendonitis model, bone marrow derived
mesenchymal stem cells were injected at the same site after three weeks of injury. The horses
were maintained on rest for 21 weeks and the tendon healing was examined using an ultrasound
during this period. Histology and immunohistochemistry revealed presence of collagen types I
and III, fiber orientation and cartilage matrix protein (COMP) after treatment showing
effectiveness in tissue regeneration on treated animals [103]. In the same study horse with
spontaneous lesions on the flexor tendon or suspensory ligament were treated with autologous
BMSC injections and went back to racing after approximately 30 weeks [103]. Thus, the
potential of stem cells to regenerate tissues was demonstrated raising the expectations to
investigate new applications and therapies.
2.8. Flow Cytometry as a Characterization Tool
Flow cytometry has been used to identify and sort different types of cells in a heterogeneous cell
population based on surface markers. Fluorescence activated cell sorting (FACS) works under
the same principle as flow cytometry but the cells can be separated. It has been used to separate
different cell populations from the same source. Sivamani et al labeled keratinocytes with cell
tracker blue (CTB, 7-amino-4-chloromethylcoumarin) and used FACS to separate them from
human bone-marrow stem cells after co-culture. In that study they showed that stem cells
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differentiate into epithelial phenotype when cultured with neonatal keratinocytes. In another
study, Trempus et al (2003), isolated murine keratinocytes from the hair follicle using flow
cytometry direct at CD34. Also real-time PCR confirmed its gene expression, demonstrating the
specificity of CD34 for keratinocytes [104].
Epidermal adult stem cells were also identified and quantitated in a human bald and hairy scalp.
This study used flow cytometry to identify cell surface markers cytokeratin 15, CD200, CD34
and integrin α-6 in cells with stem cells properties in the hair follicle bulge. Bald scalp had no
depletion of K15, showing that the absence of hair is not directly related with the stem cell
number in the hair follicle. The presence of cells high positive for CD200 and CD34, in the other
hand, was diminished on the bald scalp in comparison with the hairy scalp. This study shows that
the stem cell population may not change in certain diseases, but their differentiation potential or
pathway that the cells undergo may be the reason for tissue malfunction [105].
Keratinocytes isolated from the epidermis exhibits two major cell subpopulations, stem cells and
transient amplifying cells. Epidermal stem cells candidates were characterized as integrin-1β
positive and Rh123 low accumulation (negative); transient amplifying cells were identified by
medium expression of integrin-1β and high accumulation of Rh 123 [106]. This same study also
showed that the epidermal stem cells candidates had longer telomeres length that the integrin
negative cells, which is a characteristic of undifferentiated cells
In Veterinary Medicine flow cytometry has been used to characterize equine adipose derived
stromal cells. Although adipose derived cells are mesenchymal cells and not ectodermal cells,
these antibodies have been used to identify multipotent cells from different embryo layers.
CD90 and CD44 have been used in flow cytometry as stromal cells markers for MSCs. In a
recent study, an anti-rat CD90 monoclonal antibody cross reacted with equine tissue and mouse
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anti-horse CD44 was also positive from the adipose derived MSCs [107].

These findings

strongly suggest that equine multipotent cells express these cell surface markers.
Equine umbilical cord matrix derived cells were characterized by flow cytometry, which
confirmed expression of stem cell markers, such as Oct-4, SSEA-3, SSEA-4 and TRA-1-60. In
that study the antibodies were from mouse, rat or rabbit, again confirming cross reactivity with
equine. [108]
2.9. Regenerative Medicine-Scaffolds
Scaffolds are vital for regenerative medicine because they provide a favorable environment,
nutrients, structural support and organized cell proliferation in order to form new tissue [109].
Different biomaterials have been used to build scaffolds; there are categories such as ceramics,
natural polymers and synthetic polymers. The materials determine stiffness, biodegradability,
biocompatibility and interaction with different tissues [110]. Depending on the tissue to be
repaired, bone, ligament, tendon or skin a specific scaffold material must be chosen [111-114].
Severe skin wounding usually requires a skin substitute and dermal layer to achieve successful
healing. The re-epithelization of keratinocytes, essential for skin regeneration, depends on large
scale on the interaction between dermis and epidermis. To restore the dermis, a tissue scaffold is
crucial to guide and give structure for the new layer of cells, which will support the new
epidermis formation [115, 116]. In a burned-skin model in pigs, Liu et al (2008) used a
collagen-glycosaminoglycan scaffold loaded with MSCs to treat the wounds. Animals treated
with scaffold loaded with MSCs showed a significantly better skin healing than the one treated
just with a scaffold (no cells) or without a scaffold [114].
Tissue engineering for artificial skin requires a scaffold that provides biocompatibility, nonimmunogenity and biodegradability. Also, the cells have to form extracellular matrix which
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determines tissue structure and proper functionality [117]. Epithelial tissue reconstruction relies
on building the epithelial layer and the stromal layer that will program cell proliferation and
differentiation. Skin equivalents have been the most efficient way to reconstruct skin. These skin
equivalents are made by keratinocytes cultured in an air-liquid surface and conditions that
resemble the in vivo environment [118]. Collagen has been shown as the most efficient polymer
for dermal substitutes. [119] Together, keratinocytes and collagen, they are an important model
to reconstruct and study epithelial tissue.
Identifying proper epidermis-dermis development is an important step to determine new
therapeutic models to study and reconstruct this tissue. One important way to classify health and
differentiation level of epithelial tissue is the characterization and analysis of the keratin
expression in tissues [120, 121]. Keratins can be acidic or basic, usually are found in pairs in
vivo, one acidic and one basic [120]. Under in vitro conditions acidic keratins can be paired with
any basic polymer. There are various types of keratins present in different layers of the epithelial
tissue according to the cell differentiation stage. K5/K14 are found in the basal stratified
squamous epithelia; K1/K10 are found one the suprabasal layer of the skin and are a
differentiation-related pair and K6/K16 are found in hyperproliferative keratinocytes. [122]
Thus, identifying which keratins are present in keratinocyte cultures could give us a clear idea
about the differentiation stage of cells, which would be crucial to developing a therapeutic model
to be applied for tissue engineering.
In the equine laminae, besides the keratins, other proteins involved in the proper tissue function
can be identified to indicate tissue health and proliferation. Kuwano et al (2005), analyzed the
modifications that occurred in different stages of recovering chronic laminitic hooves. The basal
membrane zone of the laminar tissue showed alternated keratinocytes proliferation; laminin,
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collagen IV and VII low expression; absence of hemidesmosomes and fibrils. These, also would
be parameters to evaluate laminar keratinocytes and epidermis-dermis differentiation in the
equine laminar tissue once the cells are loaded and cultured in a scaffold. [123]
2.10. Conclusion
Little is known about the presence of primordial multipotent cells in equine laminar tissue.
Resources now available make it possible to identify cell population in equine laminae and
clarify events and changes that occur during clinical and subclinical laminitis. In addition,
techniques used to investigate multipotent cells from ectodermal derived tissues in humans may
provide specific ways to characterize laminar derived cells. The isolation and characterization of
progenitor cells from equine laminar tissue in health and disease may provide a key to the causes
of this devastating condition.
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3. Materials and Methods
3.1. Study Population
The study population consisted of 20 horses, 13 unaffected and 7 with laminitis, 12 geldings, 8
mares, 2 to 19 years of age, 8 thoroughbreds, 7 quarter horses, 1 tennessee walker, 1 arabian, 1,
palomino and 2 paint horse (Table 1). Laminitic horses were defined as those with a clinical
diagnosis of laminitis longer than three weeks and a white line thickness of greater than 1 cm on
sagittal section (Fig. 1)
Table 1. Horse information (CD/DT: cell doubling/doubling time; PCR; FC: flow
cytometry; IHC:immunohistochemistry; CFU)
Horse ID

Age
(years)

Condition

Gender

Breed

Outcomes
CD/DT PCR

449

3

UC

gelding

Thoroughbred

X

X

451

8

UC

mare

Thoroughbred

X

X

422

2

UC

mare

Thoroughbred

X

X

451A

4

UC

gelding

Thoroughbred

X

X

519

13

UC

mare

Quarter Horse

X

007

3

UC

gelding

Thoroughbred

289

14

UC

mare

Quarter Horse

786

9

UC

gelding

Tennessee Walker

X

X

333B

7

UC

mare

Arabian

X

X

333

7

UC

gelding

Paint Horse

X

X

460

22

UC

gelding

Palomino

X

103B

17

UC

mare

Paint Horse

X

404

10

UC

mare

Quarter Horse

719

17

LC

gelding

Quarter Horse

464

4

LC

gelding

465

4

LC

101

19

103
294A
108B

X

FC

CFU

X
X

X

X

X

X

X

Thoroughbred

X

X

X

gelding

Thoroughbred

X

X

X

LC

gelding

Thoroughbred

X

13

LC

mare

Quarter Horse

X

X

X

7

LC

gelding

Quarter Horse

X

X

X

17

LC

mare

Quarter Horse

22

IHC

X

X
X

X

X

X
X

A

B

Figure 1. Medial section of two hooves, healthy (A) and with laminitis (B), showing the
increased thickness of the laminar tissue and the phalanx characterized by the rotation of
the third phalanx
Cell Isolation
Immediately following euthanasia for reasons unrelated to this study, hooves (unaffected (UC)
and laminitic (LC) were disarticulated at the metacarpophalangeal joint. Hooves were cleaned
with a brush and bacteriostatic soap and then soaked in 10% bleach (HCl) for 60 seconds,
followed by 0.01% chlorhexidine for 30 seconds. With hooves gripped by a vice on the lateral
surfaces, a reciprocating saw with sterile blades (DeWALT, DC385, Fire&Rescue blades,
DW4865, Baltimore, MD) was used to make three 3 cuts in the hoof wall 2-3 cm apart to the
level of the third phalanx and extending from the coronary band to the toe edge, perpendicular to
the sole. The toe was then excised transversely through the tip of the third phalanx (P3). From
the cut edge at the toe, the wall was elevated with a hoof clipper to expose the laminae (Fig.1 and
2). A #10 scalpel blade was used to incise the laminar tissue to the level of P3 in a 2x3
rectangle. The tissue was undermined with the scalpel blade at the bone-lamina interface and
excised (Fig.3). The excised tissue was soaked in 0.01% chlorhexidine for 5 minutes and then
rinsed with 1X PBS with 2% antibiotic/antimycotic (Penicillin 300IU/ML, Streptomycin
300MCG/ML and Amphotericin 0.75MCG/ML(MP Biomedical, Irvine, CA)) (Fig.4). A 5 mm
section on the medial edge of the rectangle was preserved in 4% neutral buffered formalin for
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immunohistochemistry. The remaining tissue was weighed, minced and transferred to a 15ml
tube containing collagenase digest (1%g Bovine Serum Albumin (BSA) and 0.1% collagenase
type-1 in 50ml DMEM-Ham’s F12 (Hyclone, Logan, UT)) with 2% antibiotic/antimycotic
(Fig.4). Tubes were placed on a homogenizer (GyroTwister™ GX-1000, Labnet, Inc., Edison,
NJ), 55 RPM, and incubated at 37˚C for two hours. The cell solution was equally distributed
into two wells of a 6-well plate (Cell Star, Monroe, NC). The process was repeated for the
second digest, and the resulting cell pellet was resuspended in 4 ml of stromal medium (DMEMHam’s F12, 10% Fetal Bovine Serum, 1% antibiotic/ antimycotic solution) and distributed among the

remaining 4 wells of the plate. Cells were incubated over night (37C, 5% CO2). Medium was
refreshed the following day and subsequently every 2-3 days until 80% confluence (7 to10 days).
The cells were then pooled and seeded at 5 x 103 cells/cm2 in a six well plate (P0).

a
c

d

b

.
Figure 2. Tools used for hoof removal (hammer, clipper and chisel, top to bottom) and
laminae harvest (petri dishes-a, scalpel handle and scalpel blade-b, forceps-c antibiotic and
chlorhexidine washes-d).
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Figure 3. Hoof wall cleaning, removal before laminar harvest.
3.2. Cell Doubling (CD) and Doubling Time (DT)
Cells were cultured in duplicate in 12-well culture plates (Nunclon, Rochester, NY) up to P5 in
stromal medium with initial seeding densities of 5 x 103 cells/cm2. Cell numbers were quantified
in P0-P5 after 2, 4, and 6 days of culture. Cell doubling times (DT) and cell doublings (CD)
were calculated using the formulae [17]:

1. CD= ln(Nf /Ni)/ln(2) and 2.

DT= CT/CD.

CT=culture time.
3.3. Colony Forming Unit Frequencies-Limiting Dilution Assays
Fibroblastic colony forming unit (CFU-F) frequency was determined for P0, 2 and 5 using
limiting dilution assays [22]. Cells were added to a 96-well plate at 5 x 103, 2.5 x 102, 1.25 x
102, 6.25 x 10, and 3.12 x 10. 1.56 x 10, 7.8 x 10 and 3.9 x 10 cells/well, one concentration per
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column. CFU-Fs of cells from laminitic hooves were determined in fresh and cryopreserved
cells.
Following seven days of culture, wells were rinsed twice with PBS and fixed for 20 minutes in
1% paraformaldehyde in PBS at room temperature. Fixed cells were stained for 1 hour with
0.1% toluidine blue. Plates were then rinsed with tap water and colonies counted under 10x
magnification. A colony was defined as 10 cells or more. A total of ≥5 toluidine blue stained
colonies within a well was considered positive. The CFU-F frequency was calculated based on
Poisson’s principle using the formula F=e‾ x, where F = the fraction of negative wells, e =
natural logarithm constant 2.71, and x = colonies per well. Based on Poisson’s distribution of
clonal cell lineage, the value F0 = 0.37 occurs when the total number of cells in a well contains a
single CFU.

Figure 4. Laminar harvest.
26

Figure 5. Lamina in chlorhexidine wash and in 50 ml tubes before digestion.
3.4. Semi-Quantitative RT-PCR (qRT-PCR) for Target Gene mRNA Levels
P0, 2, and 5 UC and LC (n=5 horses/cohort) were used for mRNA analysis. Cells were
detached from well culture ware with 0.05% Trypsin (Hyclone, Logan, UT), rinsed with 1X PBS
and maintained in 100µL of lysis solution from RNAqueous Micro Kit (RNAqueous Micro Kit
Ambion, Inc., Austin, TX) at -80◦C until mRNA extraction. The mRNA was isolated according
to manufacturer’s instruction: added 50 µL of 100% ethanol, vortex, passed through the micro
column, centrifuged (13,000g, 10 seconds), washed twice (solutions with different ethanol
percentages provided in the kit) and eluted in 75C elution solution (kit). Potential DNA
contamination was removed by DNAse I (Turbo DNA free, Ambion, Inc., Austin, TX) digestion.
DNAse-treated RNA samples were reverse transcribed into cDNA using oligo(dT) primers and
Moloney Murine Leukemia Virus (M-MLV) reverse transcriptase (Sigma Aldrich, St. Louis,
MO). Complementary DNA (cDNA) was synthesized from 1-2μg of mRNA in all samples.
Primers for OCT4 and SOX-2, Keratins 14, 15 and 19, CD29 (integrin β1), CD44 (hyaluronic
receptor) and CD 105 (endoglin) were designed according to NCBI and checked for congruency
with the Equus caballus predicted sequence (Table 2). Target gene mRNA concentration levels
were quantified with qRT-PCR using SYBR Green technology (MJ Research Chromo4 Detector,
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Bio-Rad Laboratories). Amplicons were sequenced to confirm target sequence amplification.
The CT values were normalized to GAPDH (Glyceraldehyde 3-phosphate dehydrogenase).
Table 2. Primers sequences
Gene

NML PubMed

GAPDH

XR_131668

Forward and Reverse Primers

Protein and Relevance

CAA TGA CCC CTT CAT TGA CC
GAA GAT GGT GAT GGC CTT TC
TCG TTG CGA ATA GTC ACT GC
AGT GAGA GGC AAC CTG GAG A

Glyceraldehyde 3-phosphate dehydrogenase.
Housekeeping gene.
Octamer-binding transcription factor 4- Oct-4. Selfrenewal of undifferentiated embryonic stem cells
Sex determining region Y-box 2 - SOX-2 Selfrenewal of undifferentiated embryonic stem cells
Integrin β1Attachment of cells to the ECM and
important role in cell signaling
Hyaluronic acid receptor. Receptor hyaluronic acid,
healing process and reepithelization of extracellular
matrix
Endoglin. Part of the TGF-β receptor complex.
Affecting cytoskeleton morphology and cell
migration.
Type-II keratin. Cytoskeletal component role at the
epidermis-dermis junction.
Type-I keratin. Present in the progenitor basal cells of
the epidermis.
Type-I keratin. Responsible for the structural integrity
of epithelial cells.

OCT4

XM_001490108

SOX-2

XM_003363345

CAG CTC GCA GAC CTA CAT GA
TGG AGTG GGA GGA AGA GGT A

CD29

XM_003364340

CCA TTG TTC ACG TTG TGG AG
TTG GCA AAT TCC CTT CTG TC

CD44

NM_001085435

CAG CAC CCC TGC GGA TGA CG
TGG TCT TGG GTG GGG CGA GT

CD105

XM_003364145

CCC CAA GAG TCA ACA CCA CT
GTT CGA GAC TGC AGG AGG AC

Keratin
14

XM_001496937

TAC GAG ACG GAG CTG AAC CT
TGG CCT CTC AGG CTA TTC AT

Keratin
15

XM_001496858

GTG GCT TTG GTG ACT TTG GT
GTC TCG GAT CTT CAC CTC CA

Keratin
19

XM_001917408

GAA CCA GGA GGA AAT CA
GCT TCA GCA TCC CTG TT

3.5. Flow Cytometry
At 80%confluence, P0, 2, and 5 cells from 8 horses (5 UC and 5 LC) were evaluated with flow
cytometry using fluorescein isothiocyanate (FITC) or perierithrin (PE) labeled antibodies. Cell
aliquots of 1x 106 cells were incubated for 20 minutes with CD29, CD44 and CD105 antibodies
(Table 3). Aliquots were then centrifuged (1,200 RPM, 4 minutes, RT), washed with 2 ml of 1 X
PBS, centrifuged again, and then fixed with 30 µL 1-2% formaldehyde-PBS. Since CD29 was
unconjugated, cells were incubated with a secondary anti-mouse IgG FITC labeled antibody
(Sigma Aldrich, St Louis, MO) for 15 minutes followed by rinse with 1 X PBS and 1-2%
formaldehyde-PBS fixation.
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For intracellular antigens (keratins, table 3), cells (3 UC and 3 LC) were first permeabilized with
the Cytofix/Cytoperm kit (BD Biosciences, San Jose, CA) according to manufacturer’s
instruction. Briefly, cells were washed with 2ml of 1X PBS, centrifuged at 1200 RPM for 4
minutes and then incubated with Fixation/Permeabilization (100 µL/1 x 105 cells) solution for 20
minutes at 4˚C.

Cells were then washed with 1ml of 1X BD Perm/Wash

TM

buffer, and

centrifuged (1200 RPM, 4 minutes).

After the supernatant was decanted, cell pellet was

TM

buffer (200 µL x number of antibodies to be tested) and

resuspended in 1X BD Perm/Wash

aliquoted to separated tubes (one/antibody). Subsequently, 1 µL of each primary antibody was
added to one of the tubes and incubated for 20 minutes at 4˚C in the dark. Cells were then
washed one more time with 1 ml of 1X BD Perm/Wash TM buffer and centrifuged as before. The
supernatant was decanted, and 0.5 µL of secondary antibody, anti-mouse IgG FITC labeled
antibody (Sigma Aldrich, St Louis, MO), was added followed by additional incubation for 20
minutes at 4˚C in the dark. Cells are washed one more time as described above and 150 µL of
2% FBS in PBS is added in each tube. Flow cytometry assays were performed on FACS Calibur
flow cytometer (BD Biosciences). Data was analysed with the Cellquest Pro software (BD
Biosciences).
Table 3. Antibodies Information
Antibody
CD29

Description
integrin β-1

CD44

hyaluronic
receptor

CD105

endoglin

PE

K14

Keratin 14

N/A

K15

Keratin 15

N/A

K19

Keratin 19

N/A

Label
N/A
acid

FITC

Species
Mus
Musculus
(mouse)
Canis familiaris (dog)

Host
mouse

Homo
(human)
Homo
(human)
Homo
(human)
Homo
(human)

sapiens

mouse

sapiens

mouse

sapiens

mouse

sapiens

mouse
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mouse

Manufacture
BD Biosciences
San Jose, CA
eBiosciences
San Diego, CA.
eBiosciences
San Diego, CA
Abcam Inc
Cambridge, MA
Abcam Inc
Cambridge, MA
Abcam Inc
Cambridge, MA

3.6. Immunohistochemistry
Formalin fixed sections of lamina (1 x 0.5 x 0.5 cm) were paraffin embedded and sectioned (5
microns). Anti-keratin antibodies (table 3) were used to localize the proteins in situ. The slides
were incubated with the primary antibody (1:100) overnight at RT. After rinsing in 1x PBS three
times, the slides were incubated with the horse radish-peroxidase (HRP) conjugated secondary
antibody (1:1000) for 1 hour at RT. Color was exposed with diaminobenzidine/H2O2 (3 minutes,
RT).

Human skin and fingernail were used as positive controls and no primary antibody

incubation was used as negative control.
3.7. Cell differentiation
3.7.1. Osteogenesis
Passage 2 cells were grown to 70% confluence in stromal medium. They were then cultured in
osteogenic induction medium (DMEM-Ham’s F12, 10% FBS, 1% antibiotic/antimycotic
solution, β-glycerophosphate (10 µmol/L), dexamethasone (20 nmol/L), and sodium 2-phosphate
ascorbate (50µg/mL) for 15 more days, with media refreshed every 3 days. Cells were rinsed
with 150mM NaCl 3 times and fixed in 70% ETOH for 1 hour at 4 ˚C. After fixation, cells were
stained with a 2% Alizarin Red solution in distilled water (pH 4.1-4.3 with NaCl) for 10 minutes
at room temperature. The cells were rinsed 5 times with distilled water for light microscopic
evaluation (10X).
3.7.2. Adipogenesis
Cells were initially cultured as described above. Cells were cultured in adipogenic induction
media (DMEM-Ham’s F12, 3%FBS, 1% antibiotic/antimycotic solution, biotin (33 µmol/L),
pantothenate (17 µmol/L), insulin (1 µmol/L), isobutylmethylxanthanine (IMBX) (0.5mmol/L),
and rosiglitazone (5 µmol/L) [124] for 14 days with media refreshed as above. Cells were then
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fixed in 10% paraformaldehyde in PBS for 1 hour at 4˚C. After fixation, cells were stained with
Oil Red O for 20 minutes, rinsed with distilled water 3X and then evaluated with light
microscopy (10x). Adipogenesis was further confirmed in one sample with RT-PCR to quantify
adipogenic specific genes after seven days of culture (Table 2).
Table 4. Adipogenesis Target Gene Primer Sequences
Gene
Leptin

NML PubMed
NM_001163980

LPL

XM_001489577

PPRγ

XM_001492411

Forward and Reverse Primer
GGC TTT GGC CCT ATC TGT TC
ACC AGT GAC CCT CTG TTT GG
GAG GAC ACT TGC CAC CTC AT
TAC ATT CCT GTC ACC GTC CA
AAG GAG AAG CTG TTG GCA GA
GGT CAG TGG GAA GGA CTT GA

Protein and Relevance
Leptin: hormone expressed
proportionally to body fat-adipocytes
Lepoprotein lipase; Gene
overexpressed in adipose tissue
Peroxisome proliferator-activated
receptor gama: transcriptor factor.

3.7.3. Chondrogenesis
Cells (P2) aliquots (2.5 x 105 cells) and placed in 15 mL tubes and centrifuged at 1200 RPM for
5 minutes to form pellets. Pellets were cultured in chondrogenic medium (DMEM, 10% FBS,
ascorbate phosphate (50µg/mL), dexamethasone (100nM), proline (40µg/ml), sodium pyruvate
(2mM), TGF-β 3 (10ng/mL) and 1% ITS (6.25 µg/mL of insulin, transferin and selenious acid;
5.33 µg/mL linoleic acid, 1.25 mg/mL BSA) at 37C with 5% CO2 for 21 days with medium
refreshed every 2-3 days. Pellets were formalin-fixed, paraffin-embedded, and stained with
Alcian blue (5 μm sections).
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4. Statistical Analysis
All data is presented as mean ± standard error of the mean (SEM). CD, DT data and limit
dilution analysis were analyzed by two-way ANOVA with independent variables of passage.
Tukey’s post hoc tests were performed to assess multiple group comparisons. PCR data were
analyzed with one-way ANOVA with independent variables of passage. Unpaired t-test was used
to analyze data between cell types within passage.

A value of P <0.05 was considered

significant. Statistical analyses were evaluated using GraphPad Inc., statistical software package
(San Diego, CA).
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5. Results
5.1. Laminar Cell Isolation and Culture
Laminar harvests yielded an average of 2.83 grams of tissue. After digestion, cells were not
counted because the amount of debris that was plated with cells made counting difficult and
inaccurate. After 2 days the adherent heterogeneous population of cells could be seen, in which
different shaped cells with fibroblast-like, cobblestone-like, polygonal flattened-cells and a weblike colony of cells were observed (Fig. 6 A and B). Cells reached 80-90% confluence within 7
to 10 days, about 250,000 cells per well. Cells of P0-P5, were mostly spindle-shaped than cell
from stromal vascular fraction (Fig. 6 C and D).
B

Figure 6. Stromal vascular fraction after 2-3 days culture (A, B). First passage (P0) cells
after 5 (C) and 10 (D) days of culture.
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5.2. Laminar Cells Proliferation
Day 2 cell number was used as the initial cell number to calculate DTs and CDs for days 4 and 6
from P0 to P5. Cell doublings and doubling times were not significantly different among
passages within cell types or between cell types within passages. (Figs. 7, 8). Overall cell
doubling was significantly higher in LC, with CD 1.44 ± 0.09, and UC 1.04 ± 0.06. Mean ±
SEM CDs, P1 1.25±0.19, P2 0.91±0.10, P3 1.05±0.15, P4 0.94± 0.11, P5 1.22±0.10 and P6
0.87±0.16. DT were P1 1.02±0.15, P2 1.43±0.32, P3 1.19±0.17, P4 1.24± 0.16, P5 0.89±0.09
and P6 1.69±0.31. Cells proliferation rate was not significant different over passages. The
average ± SEM for CD at the different passages of cells harvested for 6 laminitic hooves were,
P1 1.60±0.27, P2 1.82±0.34, P3 1.32±0.22, P4 1.23±0.18, P5 1.48±0.16 and, P6 1.21±0.16. DT
were P1 1.0± 0.22, P2 0.92± 0.23, P3 1.35± 0.37, P4 1.34± 0.38, P5 1.12± 0.46 and, P6 0.99±
0.13. There was no significant difference in the expansion rate of cells isolated from laminitic
hooves. Between cells from healthy hooves and laminitic hooves there was also no significant
difference. Ages of the horses used for these experiments were not significant different between
healthy and laminitic.

Figure 7. Mean + SEM cell doublings (left) and doubling times (right) of unaffected (UC)
adult progenitor cells harvested from unaffected hooves (n=6).
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Figure 8. Mean + SEM cell doublings (left) and doubling times (right) of laminitic (LC)
adult progenitor cells harvested from laminitic hooves (n=6).

Figure 9. Cell doublings (left) and doubling times (right) comparison between unaffected
(UC) and laminitic (LC) cells.

Figure 10. Overall cell doubling and doubling time. Overall cell doubling was significant
higher in LC than in UC. Columns with different letters within graphs are significantly
different from each other (p<.05).
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5.3. Limiting Dilution Assays for Colony Forming Unit Frequencies
The UC CFU-F was 1: 3,628, 1: 1,085, and 1: 6,260 for passages P1, 3 and 6, respectively (Fig.
11 A-B). The LC CFU-F fresh was 1: 1,127, 1: 2,979, and 1: 1:53 for P0, 2 and 5, respectively.
The LC CFU-F revitalized was 1: 1,386, 1: 4,688, and 1: 1: 518 for P1, 2 and 6, respectively (Fig
11 C-D).

Figure 11. Cell colonies stained with toluidine blue (A). Colony forming unit frequencies
(mean +/- SEM) for P0, 2, and 5 of UC (B). Colony forming unit frequencies (mean +/SEM) for P0, 2, and 5 of fresh LC (C) and revitalized LC (D) P1, P3 and P6.
5.4. Quantitative PCR
The OCT4 mRNA levels were significantly higher in P2 and P5 UC compared to P0 (Fig. 12).
Notably, OCT4 mRNA levels were higher in P0 LC versus UC and significantly lower in P5 LC
compared to UC. The SOX-2 mRNA levels were significantly higher in P5 compared to P0 and
P2 in UC (Fig. 13). The P1 SOX2 levels were significantly higher in LC compared to UC.
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Relative CD29 levels (Fig. 14) were significantly higher in P5 compared to P0 and P2 in UC.
Additionally, P5 UC CD29 mRNA levels were significantly higher than LC. Expression of
CD44 levels were increased significantly with increasing passages in both UC and LC (Fig. 15).
Specifically, it was significantly higher in P5 compared to P0 and P2 LC, and significantly lower
in P0 UC compared to P2 UC which was in turn lower than P5 UC. Within passages, CD 44 was
significantly higher in LC than UC for all passages evaluated. Expression of CD105 levels were
increased significantly with increasing passages in UC, and in P5, CD105 levels were
significantly higher in UC then in LC (Fig. 16). K14 expression levels were significantly lower
in UC P5, than in P0. There was no significant difference on K14 expression between cell types
within passages (Fig. 17). Relative expression levels of K15 was not significantly different
within UC but it was significant lower at P2 and P5 when compared to P0 in LC. K15 levels
were significantly higher in LC at P2 and P5 compared to UC (Fig18). K19 expression levels
were significant higher in LC in P5 versus P0. LC expression levels of K19 was significantly
higher in P5 when compared to P5 UC (Fig.19).

Figure 12. Relative OCT4 mRNA (mean ± SEM) levels in P0, 3, and 5 UC (A), LC (B), and
UC and LC together. Columns with different lower cases letters within graphs A,B or
within passage (C) are significantly different from each other (p<.05).
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Figure 13. Relative SOX-2 mRNA (mean ± SEM) levels in P0, 3, and 5 UC (A), LC (B), and
UC and LC together. Columns with different lower cases letters within graphs A, B or
passage within graphs (C) are significantly different from each other (p<.05).

Figure 14. Relative CD29 mRNA (mean ± SEM) levels in P0, 3, and 5 UC (A), LC (B), and
UC and LC together. Columns with different lower cases letters within graphs A, B or
passage within graphs (C) are significantly different from each other (p<.05).

Figure 15. Relative CD44 mRNA (mean ± SEM) levels in P0, 3, and 5 UC (A), LC (B), and
UC and LC together. Columns with different lower cases letters within graphs A, B or
passage within graphs (C) are significantly different from each other (p<.05).
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Figure 16 . Relative CD105 mRNA (mean ± SEM) levels in P0, 3, and 5 UC (A), LC (B),
and UC and LC together. Columns with different lower cases letters within graphs A, B or
passage within graphs (C) are significantly different from each other (p<.05).

Figure 17. Relative K14 mRNA (mean ± SEM) levels in P0, 3, and 5 UC (A), LC (B), and
UC and LC together. Columns with different letters lower cases within graphs A, B or
passage within graphs (C) are significantly different from each other (p<.05).

Figure 18. Relative K15 mRNA (mean ± SEM) levels in P0, 3, and 5 UC (A), LC (B), and
UC and LC together. Columns with different lower cases letters within graphs A, B or
passage within graphs (C) are significantly different from each other (p<.05).

Figure 19. Relative K15 mRNA (mean ± SEM) levels in P0, 3, and 5 UC (A), LC (B), and
UC and LC together. Columns with different lower cases letters within graphs A, B or
passage within graphs (C) are significantly different from each other (p<.05).
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5.5. Flow Cytometry
Flow cytometry showed UC and LC express CD29, CD44 and CD105, in P0-P5 (Fi.20). Overall
a progressive decrease in the percentage of stained cells was observed from passage 0 to 5 (Fig.
21). CD44 percentage of stained cells was significant higher in LC of P0 versus P5. In UC,
CD105 percentage of stained cells was significant higher in P0 compared to P5. K14, K15 and
K19 staining was not significant different among passages in the two cell types.

Figure 20. Representative histograms of cells positive for the indicated cell surface markers
(A-C) and keratins (D-F) (black) versus autofluorescence (green).

Figure 21. Percentage (mean ± SEM) of cells expressing the indicated antigens. Within cell
types, columns with different letters are significantly different from each other (p<.05).
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5.6. Immunohistochemistry
K14, K15 and K19 were localized to the SDL-SEL junction in laminar tissue from unaffected
and laminitic hooves (Fig. 23).

Figure 22. Immunohistochemistry of laminar tissue from unaffected (A-C) and laminitic
(D-F) hooves confirming the presence and location of K14, K15 and K19.
5.7. Cell Differentiation
5.7.1. Osteogenesis
After 21 days of culture in osteogenic medium the cells formed aggregates that stained positive
for Alizarin Red, indicating calcification and osteogenic differentiation of the primordial cells.
Control cells did not get stained and kept the spindle morphology (Fig.24).

A

B

Figure 23. Equine laminar cells osteogenesis. Alizarin Red staining accumulation of
calcium (A). Control cells (B).
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5.7.2. Adipogenesis
After testing different concentration of reagents, we concluded that 5 and 10 times of all the
ingredients were toxic and killed all the cells in the plate. Medium with 2 times concentration
killed the majority of cells, but the remaining cells differentiated into adipocytes after 21 days of
culture. The regular medium induced cells to adipogenesis, but it required longer time of culture.
Because TGF- β has been reported to be involved in the mesenchymal/ectodermal switch we
added 10ng/ml in the culture medium. When comparing 1x and 2x medium, with and without
TGF-β, with the regular medium the cells were the same. Cells in adipogenesis induction
medium became round shaped. Intracellular adipose droplets were stained with Oil Red O.
Control cells did not get stained and kept the spindle morphology. Quantitative PCR showed
increased expression of early adipogenic genes, LPL, Leptin and PPR-γ (Fig.25).
B

A

C

D

Figure 24. Equine laminar cells adipogenesis. Cells morphology changing (A). Oil Red O
staining of lipid droplets after differentiation (B). Control cells (C). Expression of Leptin,
LPL and PPRγ in cells cultured 7 days in adipogenesis medium (D).
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5.7.3. Chondrogenesis
After 21 days of culture in chondrogenesis induction medium the cell formed a pellet that was
paraffin embedded and stained with Alcian Blue for collagen I (Fig. 26).

Figure 25. Equine laminar cells chondrogenesis. Cell pellet stained with Alcian Blue and
H&E (A and B). Control (C).
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6. Discussion
Laminitis has been, for uncountable years, a major reason for loss of horses. Because the
pathophysiology of the disease is not completely understood, therapies available are usually not
successful. Laminitis is the consequence of multiple insults making it challenging to fully
reproduce it with experimental models. This study is the first to evaluate a subculture of dermal
and epidermal cells isolated from the equine laminae, and determine their physiology in normal
and laminitic hooves. Knowledge of dermal and epidermal cell behavior in vitro provides a
unique approach to studying this devastating disease in naturally occurring laminitis in horses
without sacrificing horses undergoing exposure to toxic substance.
The lamina is an epidermis and dermis tissue, like the human skin, however the latter heals
injuries and wounds without complication (excluding cases with massive skin loss), while the
former no so much [125]. This is because of the unique encapsulated structure of the laminae,
healing and regeneration do not occur, and the tissue function, once disturbed, is permanently
compromised [42]. Based on our results, progenitor cells are present in the equine laminae but
are not able to regenerate the tissue after lamintis. This may be the result of a change in cell
signaling within the hoof due to different mechanical and biochemical stimuli.
Overall higher cell doubling of cells from laminitic hooves is congruent with the
hyperproliferation of the epidermal basal cells during laminitis. Identified progenitor cell surface
markers and target genes, such as OCT-4, SOX-2, CD105, CD29 and CD44, in all subcultures of
both types of laminar cells (UC and LC), were consistent with stromal cells derived from equine
adipose and bone marrow in our laboratory, confirming the isolates were progenitor cells. The
fact that cells could be cryopreserved and form colonies after being revitalized also adds to their
progenitor characteristics.
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Interestingly, OCT4 and SOX-2 expression was significantly higher in cells from laminitic
hooves. Both genes are related to cell self-renewal, indicating that the laminitic tissue may be
working toward healing and replacing the damaged tissue. Cells also may not be undergoing
proper differentiation due to inflammatory and mechanical stimuli present in chronic laminitis.
In addition, laminitis is also characterized by hyperproliferation of basal epidermal laminar cells.
The hyperproliferation of cells in tumors is attributed OCT4 and SOX2 [126, 127]. In UC the
fact that these two genes expression were significantly higher in passage 5, when compared to
passage 0, indicates cells keep progenitor properties in vitro. Higher expression of these two in
LC indicates that cells within the hoof do not lose their progenitor properties during laminitis.
Cells surface markers CD29, CD44 and CD105 mRNA expression showed a variation between
different cells sources or through passages. CD29, or integrin β-1, has been identified on
epidermal stromal cells [106]. Expression of CD29 was slightly higher in cells from unaffected
hooves, which can be interpreted in two ways, 1) there are enough progenitor cells in laminitic
hooves, but because the insult (e.g. inflammatory cytokines), are not able to promote healing 2)
progenitor cells in laminitic hooves may be undergoing early or not suitable differentiation. In
vitro, increased CD29 mRNA expression suggests these cells maintain progenitor properties after
multiple passages.
CD44 is the receptor for the hyaluronic acid, and it is involved in cell migration and adhesion. It
is a cell membrane ligant for many proteins such as metalloproteinases (MMPs). In laminitis
MMP-2 and MMP-9 have been reported to be present in higher levels, which is intimately
related to the ECM degradation [66]. Malignant epithelial tumors, such as ovarian and breast,
overexpress CD44, MMP-2, and MMP-9. Upregulation of CD44 is related to elevated cell
growth, inflammatory response and metastases [128, 129]. Metastasis occurs following cell
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migration due to ECM degradation. Significantly higher expression of CD44 mRNA in cells
from laminitic hooves may be related to signaling and functioning MMPs in the laminar tissue
contributing to the ECM degradation and dermis-epidermis separation [130]. There is also
distinct exon usage for CD44 as a function of tissue and tumor type. This could also be a
mechanism of action for relative CD44 expression levels between UC and LC.
Endoglin or CD105 is part of the TGF-β receptor complex. It is involved in cytoskeleton
organization affecting cell morphology and migration [131]. Endoglin is critical to maintain
vascular development and homeostasis [132]. The higher expression of CD105 in LC, may be
related to tissue action to compensate with new angiogenesis vascular structures that are
damaged due to laminitis [43]. CD105 has also been described in epithelial cancers, such as
prostate, and its expression is directly proportional to the vascularization and metastatic
characteristics of tumors, therefore is related to the tumor growth capacity [133, 134]. In
laminitis stimulation of vascularization may be related to the hyperproliferation of the basal
epidermal cells and an attempt to vascularize the new tissue.
Specific keratins are present in different epithelial tissues. Lower keratin 14 expression level in
cells harvested from laminitic hooves may be because hooves have fewer keratinoblasts. Keratin
14 mutation in humans is related to patients who develop epidermolysis bullosa, which, like
laminitis, is a disease caused by the separation of layers of the skin (dermis and epidermis)
resulting in blistering [135]. Decreased number of cells expressing K14 may be contributing to
lamintis. Significantly decreased keratin 14 expression in UC in passage 0 versus 5, which is not
observed in cells from laminitic hooves, may indicate that some cells undergo apoptosis in vitro
or passaging is selecting for cells that do not express K14. Laminar subcultured cells change
their properties in a different manor depending on the cell source.
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Keratin 15 has been described in basal epithelial progenitor cells in humans. Lower expression
of keratin 15 occurs in activated keratinocytes, a condition seen in hyperproliferating diseases
such as psoriasis and hypertrophic scars [136].

Considering that, in laminitis, there is a

histopathologic evidence of tissue hyperproliferation and formation of fibrous tissue, lower
expression of K15 in our results indicates that may be a higher activation of keratinocytes during
laminitis and this may be affecting cell proliferation in the tissue. Recently keratin 15 expression
has been shown in injured mature epidermis reflecting activity and responsiveness of basal cells
to loss of tissue homeostasis of the epidermal differentiation program [137]. Hyperproliferation
of epidermal basal cells in laminitis may be related to the keratin 15 expression levels.
Keratin 19 has been described as an epidermal stem cell marker [138]. In this study there was no
significant difference between its expression in cells derived from unaffected or laminitic
hooves. This suggests that, in laminitis, the number of progenitor cell may not decrease, but
instead, the cell signaling cause changes in the fate of the progenitor cells and their
differentiation capability. Significantly increase keratin 19 expression over passages in LC
indicate that cell passaging may be selecting for less epithelial differentiated cells.
The percentage of positive stained cells over passages by flow cytometry was not congruent to
mRNA levels for all cohorts, which could be explained by translation and post-translation
modifications. The location of progenitor epidermal proteins K14, K15 and K19, determined by
immunohistochemistry, corresponds to the region of laminar failure, indicating that the changes
in the expression of these proteins may be directly involved in laminitis. Both results confirm
the progenitor characteristic of cells from the laminar tissue and indicate specific differences
between healthy and laminitic tissue.
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The multipotentiality of these cells indicate that cells harvested from the equine laminae are able
to undergo early differentiation stages of osteogenesis, adipogenesis and chondrogenesis in vitro,
which confirms the cells progenitor properties.
Overall the mRNA expression of all the genes studied had a similar pattern over passages in cells
from unaffected hooves and the opposite pattern in cells from laminitic hooves. Some genes
associated with “progenitor”, such as OCT4, SOX-2, CD29, CD44 and CD105, had an increased
expression from P0 versus P5 in cells from healthy hooves. The opposite was observed only for
K14 and K15. This indicates that passaging cells from the unaffected hooves is either selecting
for progenitor cells or somehow de-differentiating the cells, since the epithelial signals are no
longer present in vitro. Interestingly cells of passage 0 from laminitic hooves compared to cells
from unaffected hooves had higher expression of the same genes.

This may be because

progenitor cells from laminitic hooves are changed and may not differentiate into the proper cell
lineage and therefore still express higher levels of progenitor genes. These results give a novel
clue of the pathophysiology of laminitis and the events that occur at the cellular level.
Progenitor cells from the unique niche of the equine laminar tissue can be then expanded, studied
and possibly used as a therapeutic tool.
On the other hand, over passages, cells from laminitic hooves showed decreased expression of
OCT4, SOX-2 and CD105, but increased expression of CD44, CD29, K15 and K19 may indicate
that progenitor cells harvested from laminitic hooves, once no longer exposed to the laminitis
causes tend to adjust to their programmed fate, increasing expression of some specific epithelial
genes. The fact that cells have a significant change of several genes expression in vitro shows
that in order to study cells from the equine laminae must be done in earlier passages because
later passages no longer represent accurately the tissue of origin.
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Specific niche progenitor cells such as keratinocytes have been successfully used to generate
human skin equivalents (HSE) under specific conditions [40].

Cells derived from equine

laminae can be a source of a specific stem cell niche that can be expanded in vitro and later be
applied clinically. The capability of equine laminar cells to differentiate into different cell
lineages is one of the first ones and suggests the possibility of inducing these cells into ones
similar to epidermal and dermal those are encountered in the laminae. The differences in gene
expression, cell surface markers and keratins of cells from healthy and laminitic hooves, and
their modifications along passages has the potential to provide novel insights into the
pathogenesis of the diseases at a cellular level.
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7. Summary and Conclusion
Cells from equine laminar tissue, healthy and with laminitis were harvested and subcultured in
vitro. Overall cell doubling (CD) was significant different between cell type and doubling time
(DT) was not different between cells from the different sources. Passages did not influence
significantly CD or DT.
Specific genes and cell surface markers, such as OCT4, SOX-2, CD44, CD29, CD105, K14, K15
and K19, were identified and quantified.

A gene expression variation was detected when

comparing cells from different sources; cells derived from laminitic hooves had higher
expression levels at passage 0, indicating laminitis have an effect on the differentiation of
laminar cells. Over passages (from 0 to 5) the expression of most of these genes in vitro
followed a changing pattern. That is, cells from unaffected hooves showed an increase in
expression of most of the genes studied from passage 0 to 5, while cells from laminitic hooves
showed a decrease in expression of the same genes. The differences observed on cells from the
difference sources were either maintained or accentuated over passage.
In the present study we developed a method to harvest cells from the equine laminae providing a
new approach to investigate cells affected by laminitis. We were able to localize keratins and
other cell proteins within laminar tissues by using antibodies that cross react with horse tissues.
We validated that antibodies of other species (human, mouse, dog) cross-reacted with equine
keratinocytes, thus expands tools that can be used to study these cell in normal horses and horses
with laminitis.
In conclusion cells from the equine laminae were harvested, cultured and characterized in normal
and laminitic hooves.

Cells from laminitic hooves in general have higher expression of

progenitor genes indicating that the progenitor cells do not undergo proper differentiation, due to
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the disease. Expansion properties of these cells make them a possible therapeutic tool specially
because cells from healthy hooves increase expression of progenitor genes after passages.
Exploring the immunogenicity of these cells after passages would be a next step toward clinical
application. Progenitor cells from the lamina are from a specific niche and could be cultured in
scaffolds and applied in laminitic hooves to guide new laminar tissue formation.
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